| 311 |
GENTAMICIN 0.1 % |
GENTAMICIN SULFATE 0.17% W/W EQ.TO GENTAMICIN 0.1% W/W. |
CREAM |
Tube |
TREATMENT OF IMPETIGO ERYTHEMA AND OTHER LOCALISED PRIMARILY BACTERIAL SKIN INFECTION WITH A GRAM-NEGATIVE COMPONENT AND ALSO FOR SECONDARY BACTERIAL INFECTIONS |
Yes |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
11 I 4628/18 |
09-ม.ค.-2025 |
08-ม.ค.-2030 |
View |
| 312 |
GLIMICRON 80 |
GLICLAZIDE 80 MG |
TABLET |
ALU-PVC BLISTER |
NON - INSULIN DEPENDENT DIABETES MELLITUS. |
No |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
06 I 4041/15 |
09-ม.ค.-2025 |
08-ม.ค.-2030 |
View |
| 313 |
HOFTREX |
CEFTRIAXONE SODIUM EQ. TO CEFTRIAXONE 1 G |
POWDER FOR SOLUTION FOR INJECTION |
VIAL |
BONE AND JOINT INFECTION, UNCOMPLICATED GONORHHOEA, INTRA-ABDOMINAL INFECTIONS, LYME DISEASE, MENINGITIS, OTITIS MEDIA, FEMALE PELVIC INFECTIONS, RESPIARATORY TRACT INFECTION PARTICULARLY BACTERIAL PNEUMONIA, BACTERIAL SEPTICAEMIA, SKIN AND SOFT TISSUE INFECTIONS, BACTERIAL URINARY TRACT INFECTIONS |
Yes |
BMS PHARMA SOLE CO.,LTD |
NECTAR LIFESCIENCES LIMITED (UNIT-VI) |
MALAYSIA |
CERTIFICATE RELEASED |
05 I 4703/19 |
2022-09-08 |
2025-09-07 |
View |
| 314 |
HOSEDYL DM COUGH LINCTUS |
EACH 5 ML CONTAINS: PROMETHAZINE HYDROCHLORIDE 3.6 MG
DEXTROMETHORPHAN HYDROBROMIDE 15 MG |
SYRUP |
BOTTLE |
FOR SHORT TERM SYMPTOMATIC RELIEF OF TROUBLESOME NON - PRODUCTIVE COUGH AND COMMON COLD, PARTICULARLY AT NIGHT. |
No |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
07 I 4171/16 |
2023-06-07 |
2026-06-06 |
View |
| 315 |
HOSOLVON |
BROMHEXINE HYDROCHLORIDE 8 MG |
TABLET |
BLISTERPACK |
REDUCTION OS SPUTUM VISCOSITY |
No |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
04 I 4916/20 |
2023-08-18 |
2026-08-17 |
View |
| 316 |
HOSOLVON ELIXIR |
BROMHEXINE HYDROCHLORIDE 4 MG/5 ML |
SYRUP |
BOTTLE |
SECRETOLYTIC THERAPY IN ACUTE AND CHRONIC BRONCHOPULMONARY DISEASES ASSOCIATED WITH ABNORMAL MUCUS SECRETION AND IMPAIRED MUCUS TRANSPORT |
No |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
05 I 4704/19 |
2023-12-11 |
2026-12-10 |
View |
| 317 |
HOVASC 10 MG |
AMLODIPINE BESILATE 13.8 MG EQ.TO AMLODIPINE 10 MG |
TABLET |
ALU-PVC BLISTER |
FIRST LINE TREATMENT OF HYPERTENSION AND CAN BE USED AS THE SOLE AGENT TO CONTROL BLOOD PRESSURE IN THE MAJORITY OF PATIENTS. |
Yes |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
06 I 4037/15 |
09-ม.ค.-2025 |
08-ม.ค.-2030 |
View |
| 318 |
HOVASC 5 MG |
AMLODIPINE BESILATE 5 MG |
TABLET |
BLISTERPACK |
AMLODIPINE IS INDICATED FOR THE FIRST LINE TREATMENT OF HYPERTENSION AND CAN BE USED AS THE SOLE AGENT TO CONTROL BLOOD PRESSURE IN THE MAJORITY OF PATIENTS NOT ADEQUATELY CONTROLLED ON A SINGLE ANTIHYPERTENSIVE AGENT MAY BENEFIT FROM THE ADDITION OF AMLO |
Yes |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
07 I 4167/16 |
2023-06-07 |
2026-06-06 |
View |
| 319 |
HOVID MEROPENEM FOR INJECTION 1 G |
STERILE MEROPENEM TRIHYDRATE USP EQ.TO ANHYDROUS MEROPENEM 1000 MG, STERILE SODIUM CARBONATE USP EQ.TO SODIUM 90.2 MG ( ADDED AS BUFFER) |
POWDER FOR INJECTION |
VIAL |
SEVERE PNEUMONIA, INCLUDING HOSPITAL AND VENTILATOR-ASSOCIATED PNEUMONIA, BRONCHO-PULMONARY INFECTIONS IN CYSTIC FIBROSIS, COMPLICATED URINARY TRACT INFECTION, COMPLICATED INTRA-ABDOMINAL INFECTIONS, INTRA - AND POST- PARTUM INFECTION, COMPLICATED SKIN AND SOFT TISSUE INFECTION, ACUTE BACTERIAL MENINGITIS. |
Yes |
BMS PHARMA SOLE CO.,LTD |
BROOKS STERISCIENCE LIMITED |
MALAYSIA |
CERTIFICATE RELEASED |
06 I 5539/23 |
2023-06-26 |
2026-06-25 |
View |
| 320 |
HOVID SULBACYN FOR INJECTION 1.5 G |
AMPICILLIN SODIUM EQ.TO AMPICILLIN 1 G AND SULBACTAM SODIUM EQ.TO SULBACTAM 0.5 G |
POWDER FOR INJECTION |
VIAL |
SKIN AND SKIN STRUCTURE INFECTIONS CAUSED BY BETA-LACTAMASE PRODUCING STRAINS OF STAPHYLOCOCCUS AUREUS, E.COLI. KLEPSIELLA SPP. (INCLUDING K.PNEUMONIAE), PROTEUS MIRABILIS, BACTEROIDES FRAGILIS, ENTEROBACTER SPP., AND ACINETOBACTER CALCOACETICUS. INTRA-ABDOMINAL INFECTIONS CAUSED BY BETA-LATAMASE PRODUCING STRAINS OF E.COLI, KLEPSIELLA SPP, (INCLUDING K.PNEUMONIAE), BACTEROIDES SPP. (INCLUDING B.FRAGILIS), AND ENTEROBACTER SPP. GYNECOLOGICAL INFECTIONS CAUSED BY BETA-LATAMASE PRODUCING STRAINS OF E.COLI, BACTEROIDES SPP. (INCLUDING B.FRAGILIS). |
No |
BMS PHARMA SOLE CO.,LTD |
REYOUNG PHARMACEUTICAL CO., LTD |
MALAYSIA |
CERTIFICATE RELEASED |
06 I 5540/23 |
2023-06-26 |
2026-06-25 |
View |
